• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种抗糖尿病噻唑烷二酮类药物对Zucker糖尿病肥胖大鼠和db/db小鼠肥胖基因表达的下调作用

Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.

作者信息

Zhang B, Graziano M P, Doebber T W, Leibowitz M D, White-Carrington S, Szalkowski D M, Hey P J, Wu M, Cullinan C A, Bailey P, Lollmann B, Frederich R, Flier J S, Strader C D, Smith R G

机构信息

Department of Molecular Endocrinology, Merck Research Laboratories, Rahway, New Jersey 07065, USA.

出版信息

J Biol Chem. 1996 Apr 19;271(16):9455-9. doi: 10.1074/jbc.271.16.9455.

DOI:10.1074/jbc.271.16.9455
PMID:8621615
Abstract

Obese (ob) is a recently identified gene involved in the regulation of energy balance in the mouse. We report here that AD-5075, a potent thiazolidinedione which lowered plasma glucose and triglyceride in Zucker diabetic fatty (ZDF) rats and db/db mice, decreased the expression of the ob gene in these animal models of obesity and non-insulin-dependent diabetes mellitus. The level of adipose ob mRNA in ZDF rats was 3-fold greater than that detected in the Zucker lean littermates. Chronic treatment with AD-5075 elicited a 67 and 70% reduction of ob mRNA in ZDF and control lean rats, respectively. Furthermore, the amount of adipose ob mRNA in db/db mice was 7 times higher than that detected in lean littermates. Treatment of db/db mice with AD-5075 resulted in a 78% reduction of the level of ob mRNA with parallel changes in circulating level of the ob gene product, leptin. The reduction of the ob mRNA in the Zucker lean rats was accompanied by significantly greater food intake and weight gain. However, in ZDF rats and db/db mice, there was profound increase in body weight without hyperphagia. The results demonstrate that the expression of the ob gene is up-regulated in these two rodent models of diabetes compared to their lean counterparts and that such overexpression is attenuated by treatment with an agent that improves insulin sensitivity and glucose homeostasis in vivo.

摘要

肥胖(ob)基因是最近在小鼠中发现的参与能量平衡调节的基因。我们在此报告,AD - 5075是一种强效噻唑烷二酮类药物,可降低Zucker糖尿病脂肪(ZDF)大鼠和db/db小鼠的血糖和甘油三酯水平,在这些肥胖和非胰岛素依赖型糖尿病动物模型中,它能降低ob基因的表达。ZDF大鼠脂肪组织中ob mRNA水平比其瘦的同窝对照大鼠高3倍。用AD - 5075长期治疗后,ZDF大鼠和对照瘦大鼠的ob mRNA水平分别降低了67%和70%。此外,db/db小鼠脂肪组织中ob mRNA的量比其瘦的同窝对照小鼠高7倍。用AD - 5075治疗db/db小鼠后,ob mRNA水平降低了78%,同时ob基因产物瘦素的循环水平也发生了相应变化。Zucker瘦大鼠中ob mRNA的减少伴随着食物摄入量和体重的显著增加。然而,在ZDF大鼠和db/db小鼠中,体重显著增加但没有食欲亢进。结果表明,与它们的瘦同窝对照相比,这两种啮齿类糖尿病模型中ob基因的表达上调,并且用一种能在体内改善胰岛素敏感性和葡萄糖稳态的药物治疗可减弱这种过表达。

相似文献

1
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.一种抗糖尿病噻唑烷二酮类药物对Zucker糖尿病肥胖大鼠和db/db小鼠肥胖基因表达的下调作用
J Biol Chem. 1996 Apr 19;271(16):9455-9. doi: 10.1074/jbc.271.16.9455.
2
Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.大鼠严重肥胖导致食欲素基因表达下调:对Zucker肥胖大鼠和Zucker糖尿病肥胖大鼠的研究及罗格列酮的作用
Brain Res Mol Brain Res. 2000 Apr 14;77(1):131-7. doi: 10.1016/s0169-328x(00)00041-3.
3
Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.新型口服抗糖尿病药物CS-045的特性研究。在KK小鼠、ob/ob小鼠和 Zucker 肥胖大鼠中的研究。
Diabetes. 1988 Nov;37(11):1549-58. doi: 10.2337/diab.37.11.1549.
4
Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.小鼠肥胖时肝脏中过氧化物酶体增殖物激活受体(PPAR-α)和PPAR-γ信使核糖核酸表达上调:曲格列酮诱导肥胖糖尿病小鼠肝脏中PPAR-γ反应性脂肪组织特异性基因的表达。
Endocrinology. 2000 Nov;141(11):4021-31. doi: 10.1210/endo.141.11.7771.
5
Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents.正常(斯普拉格-道利大鼠)和肥胖(db/db小鼠、fa/fa大鼠)啮齿动物脂肪组织中ob mRNA水平的长期和快速调节。
Diabetologia. 1996 Jul;39(7):758-65. doi: 10.1007/s001250050508.
6
Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.噻唑烷二酮类药物MCC - 555治疗肥胖型脂肪(fa/fa) Zucker大鼠和Zucker糖尿病脂肪(ZDF)大鼠可改善其代谢状态和胰岛素敏感性。
Br J Pharmacol. 1998 Dec;125(8):1708-14. doi: 10.1038/sj.bjp.0702245.
7
Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.噻格列酮,一种新型降糖药。I. 对ob/ob和db/db小鼠、糖尿病中国仓鼠以及正常和链脲佐菌素诱导糖尿病大鼠的研究。
Diabetes. 1983 Sep;32(9):830-8. doi: 10.2337/diab.32.9.830.
8
Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats.大鼠肥胖cDNA的分子克隆及遗传性肥胖Zucker脂肪型(fa/fa)大鼠中基因表达的增强
J Clin Invest. 1995 Sep;96(3):1647-52. doi: 10.1172/JCI118204.
9
Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.在肥胖型2型糖尿病动物模型中,曲格列酮可改善脂肪组织中葡萄糖转运蛋白4(GLUT4)的表达。
Diabetes Res Clin Pract. 2002 Jun;56(3):159-71. doi: 10.1016/s0168-8227(01)00373-4.
10
Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.罗格列酮,一种新型过氧化物酶体增殖物激活受体-γ激动剂,在肥胖型糖尿病啮齿动物模型中具有显著的抗糖尿病作用。
J Pharmacol Sci. 2009 Oct;111(2):155-66. doi: 10.1254/jphs.09084fp. Epub 2009 Oct 6.

引用本文的文献

1
Leptin signaling in breast cancer and its crosstalk with peroxisome proliferator-activated receptors α and γ.瘦素信号在乳腺癌中的作用及其与过氧化物酶体增殖物激活受体α和γ的相互作用。
Clin Transl Oncol. 2023 Mar;25(3):601-610. doi: 10.1007/s12094-022-02988-4. Epub 2022 Nov 8.
2
PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes.PPARγ2基因Pro12Ala多态性与儿童2型糖尿病易感性相关性状有关。
Front Pharmacol. 2021 Nov 23;12:763853. doi: 10.3389/fphar.2021.763853. eCollection 2021.
3
A noncanonical PPARγ/RXRα-binding sequence regulates leptin expression in response to changes in adipose tissue mass.
非典型的 PPARγ/RXRα 结合序列调节瘦素表达以响应脂肪组织质量的变化。
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6039-E6047. doi: 10.1073/pnas.1806366115. Epub 2018 Jun 11.
4
Extract Ameliorates Type 2 Diabetes via Regulation of MAPK and PI3K/Akt Signaling.提取物通过调节 MAPK 和 PI3K/Akt 信号通路改善 2 型糖尿病。
Nutrients. 2018 Jan 6;10(1):51. doi: 10.3390/nu10010051.
5
Effects of pioglitazone treatment on blood leptin levels in patients with type 2 diabetes.吡格列酮治疗对 2 型糖尿病患者血瘦素水平的影响。
J Diabetes Investig. 2018 Jul;9(4):917-924. doi: 10.1111/jdi.12783. Epub 2017 Dec 25.
6
Fatty acids derived from a food frequency questionnaire and measured in the erythrocyte membrane in relation to adiponectin and leptin concentrations.来源于食物频率问卷的脂肪酸与红细胞膜中的脂联素和瘦素浓度相关。
Eur J Clin Nutr. 2014 May;68(5):555-60. doi: 10.1038/ejcn.2014.36. Epub 2014 Mar 19.
7
The diabetic heart: too sweet for its own good?糖尿病与心脏:甜蜜过头也不妙?
Cardiol Res Pract. 2012;2012:845698. doi: 10.1155/2012/845698. Epub 2012 Feb 22.
8
Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?脂肪组织介导的炎症:肥胖与心血管疾病之间缺失的环节?
Intern Emerg Med. 2009 Feb;4(1):25-34. doi: 10.1007/s11739-008-0207-2. Epub 2008 Dec 4.
9
A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells.一种过氧化物酶体增殖物激活受体γ配体可调节人肝星状细胞上瘦素受体的表达。
Histochem Cell Biol. 2007 May;127(5):495-502. doi: 10.1007/s00418-007-0282-x. Epub 2007 Mar 29.
10
Nuclear receptor corepressors and PPARgamma.核受体共抑制因子与过氧化物酶体增殖物激活受体γ
Nucl Recept Signal. 2006;4:e003. doi: 10.1621/nrs.04003. Epub 2006 Feb 8.